49. Федеральный закон Российской Федерации от 12 апреля 2010 г. N 61-фз "Об обращении лекарственных средств"

50. E. Meehan et al. A microinfusor device for the delivery of therapeutic levels of peptides and macromolecules / // J. Control. Releas.— 1996.-Vol. 46.- P. 107-316.

51. Consultative Document. Interchangeable multy — source pharmaceutical

products WHO draft guideline on marketing authorization requirements //WHO Drug Information. 1994.— 8(2): 71—83.

52. FIP guidelines for dissolution Testing of solid oral Products // Final Draft.- Pharmacopeial Forum.- 1995.— Vol. 21.— № 5.— S. 1371-1379.

53. M. Sugimoto et al. Improvement of dissolution characteristics and bioavailability of poorly water-soluble drugs by novel cogrinding method using water-soluble polymer // Int. J. Pharm.— 1998.— Vol. 160.— P. 11—19.

54. R. Guy et al. Investigation of bioavailability and bioeguivalence. The rules governing medicinal products in the European Community // 1992.— III.— P. 149—168.

55. Iontophoresis: electrorepulsion and electroosmosis //J. Control. Release.-2000.— Vol. 64.— P. 129—132.

55. Jackson K., Young D., Pant S. Drug-excipient interactions and their affect on absorption // Pharmaceutical science and technology today.-2000.- Vol. 3.— No. 10.— P. 336—345.

56. Li pinski C., Lombardo F., Dominy B., Feeney P. Experimental and computational approaches to estimate solubility and permeability in drug discovery and permeability in drug discovery and development settings //Adv. Drug. Deliv. Rev.— 1997.— Vol. 23.— P. 3—25.

57. Martindale. The Extra Pharmacopeia.— London: Pharm. Press, 1982.-2025 p.

58. Microfabricated microneedless; a novel approach to transdermal drug delivery / S. Henry et al. // J. Pharm. Sci.— 1998.— Vol. 87.— P. 922-925.

59. Muller B. W. (Hrsg. ). Suppositorien. Pharmakologie, Biopharmazie und Galenik rektal und vaginal anzuwendender Arzneiformen.- Stuttgart: Wiss. Verlagsgesellschaft mbH, 1986.

60. Multisource (genetic) pharmaceutical products: guidelines on registration

requirements to establish interchangeability // WHO Technical Report series, 1992.— № 863.— P. 114—154.

61. Naik A., Kalia Y.N., Guy R. Transdermal drug delivery: overcoming the

skin’s barrier fuction // Pharmaceutical science and technology today.-2000.- Vol. 3,— N 9.— P. 318—326.

62. Notari R. E. Biopharmaceuticas and Clinical Pharmacokineticas (An Introduction).- 3. Aufl.— New York; Basel: Marcel Dekker Inc., 1980.

63. Notari R. E. Biopharmaceuticas and Clinical Pharmacokineticas (An Introduction).— 3. Aufl.— New York; Basel: Marcel Dekker Inc., 1980.

64. Panchagnula P., Thomas N. Biopharmaceutics and pharmacokinetics in drug research // Int. J. Pharmac.— 2000.— P. 131—150.

65. FDA, Electronic Orange Book, Approved Drug Products with Therapeutic Equivalence Evaluations, 20th Edition, 2000

66. FDA, Electronic Orange Book. 23th Edition, 2003

67. The rules governing medicinal products in the European Union. Investigation of Bioavailability and Bioequivalence, v. 3C, 1998, pp. 231-244).